greeksoup/ stock research
Stock research / United States / Funds / Arrowpoint Investment Partners (Singapore) Pte. Ltd.

Arrowpoint Investment Partners (Singapore) Pte. Ltd.

CIK 2032331 · latest 13F filed 13 August 2026 · Read the filing on EDGAR

Arrowpoint Investment Partners (Singapore) Pte. Ltd. reported 124 US-listed holdings worth $339.9 million in its 13F for the quarter ended 30 June 2026, filed 13 August 2026. Its largest: Citigroup Inc. (9.7%), Goldman Sachs Group Inc. (9.2%) and Global Payments Inc. (8.2%). Against the quarter before, it opened 82 positions, added to 23, trimmed 19 and sold out of 34.

Reported holdings$339.9M+405.3% on Q1 2026
Positions124+48 on Q1 2026
The largest ten63.9%of its reported holdings
Latest 13FQ2 2026filed 13 August 2026
Where the money is
OpenedAdded to
C9.7%GS9.2%GPN8.2%NSC7.5%AEP7.5%NVDA7.4%XOM7.2%GOOGL3.6%MU2.2%INTC1.4%SNDK1.3%ARGX1.2%INFY1.1%CAT1.1%110 more31.3%

The 14 largest of its 124 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q4 2024: $164.2 million in 226 positions$164MQ4 24Q1 2025: $214.6 million in 298 positions$215MQ1 25Q2 2025: $56.6 million in 34 positions$56.6MQ2 25Q3 2025: $67.2 million in 67 positions$67.2MQ3 25Q4 2025: $678.7 million in 104 positions$679MQ4 25Q1 2026: $67.3 million in 76 positions$67.3MQ1 26Q2 2026: $339.9 million in 124 positions$340MQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned +33.5% over the 6 quarters to 30 June 2026, against +27.4% for the S&P 500.

Its reported holdingsThe S&P 500
90105120135Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Its holdings +33.5%S&P 500 +27.4%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Opened 82Added 23Trimmed 19Sold out 34
Opened: 82Added: 23Trimmed: 19Sold out: 34

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Opened 82

  1. Citigroup Inc. C$32.9 million
  2. Goldman Sachs Group Inc. GS$31.3 million
  3. Global Payments Inc. GPN$27.9 million
  4. Norfolk Southern Corp. NSC$25.6 million
  5. American Electric Power Co. Inc. AEP$25.4 million
  6. NVIDIA Corp. NVDA$25.1 million
  7. ExxonMobil Holdings Corp. XOM$24.5 million
  8. Micron Technology Inc. MU$7.5 million

and 74 more in the table below

Added to 23

  1. Eli Lilly & Co. LLY+2,106 shares · +476%
  2. Madrigal Pharmaceuticals Inc. MDGL+4,673 shares · +392%
  3. Insmed Inc. INSM+23,152 shares · +330%
  4. Cooper Companies, Inc. COO+28,847 shares · +489%
  5. Teva Pharmaceutical Industries Ltd. TEVA+56,188 shares · +218%
  6. Alphabet Inc. GOOGL+3,430 shares · +11%
  7. UnitedHealth Group Inc. UNH+2,441 shares · +47%
  8. Twist Bioscience Corp. TWST+6,811 shares · +51%

and 15 more in the table below

Trimmed 19

  1. Ionis Pharmaceuticals Inc. IONS-26,650 shares · -68%
  2. Biomarin Pharmaceutical Inc. BMRN-21,678 shares · -44%
  3. Neurocrine Biosciences Inc. NBIX-5,066 shares · -24%
  4. Protagonist Therapeutics, Inc. PTGX-6,036 shares · -65%
  5. Axsome Therapeutics Inc. AXSM-2,570 shares · -16%
  6. Belite Bio Inc. BLTE-3,996 shares · -67%
  7. Select Sector SPDR Trust XLI-2,900 shares · -88%
  8. Select Sector SPDR Trust XLP-6,000 shares · -95%

and 11 more in the table below

Sold out of 34

  1. ASE Technology Holding Co., Ltd. ASX$3.9 million last quarter
  2. Ascendis Pharma A/s ASND$2.7 million last quarter
  3. Pfizer Inc. PFE$2.0 million last quarter
  4. Regeneron Pharmaceuticals, Inc. REGN$1.9 million last quarter
  5. Johnson & Johnson JNJ$1.9 million last quarter
  6. Amgen Inc. AMGN$1.7 million last quarter
  7. Gilead Sciences, Inc. GILD$1.7 million last quarter
  8. Vertex Pharmaceuticals Inc. VRTX$1.5 million last quarter

What it holds

CompanySharesValueOf its bookChange in shares
Citigroup Inc. C235.0K$32.9 million9.68%new
Goldman Sachs Group Inc. GS31.0K$31.3 million9.21%new
Global Payments Inc. GPN384.1K$27.9 million8.20%new
Norfolk Southern Corp. NSC81.3K$25.6 million7.53%new
American Electric Power Co. Inc. AEP186.0K$25.4 million7.48%new
NVIDIA Corp. NVDA125.5K$25.1 million7.39%new
ExxonMobil Holdings Corp. XOM179.3K$24.5 million7.21%new
Alphabet Inc. GOOGL34.6K$12.3 million3.63%+3.4K
Micron Technology Inc. MU6.5K$7.5 million2.21%new
Intel Corp. INTC33.4K$4.7 million1.37%new
Sandisk Corp. SNDK2.0K$4.6 million1.34%new
argenx SE ARGX4.4K$4.1 million1.20%new
Infosys Limited INFY367.1K$3.9 million1.13%new
Caterpillar Inc. CAT3.5K$3.8 million1.11%new
Axsome Therapeutics Inc. AXSM13.8K$3.4 million1.00%-2.6K
Insmed Inc. INSM30.2K$3.2 million0.95%+23.2K
UnitedHealth Group Inc. UNH7.7K$3.2 million0.94%+2.4K
Bruker Corp. BRKR52.8K$3.2 million0.93%new
Madrigal Pharmaceuticals Inc. MDGL5.9K$3.1 million0.93%+4.7K
Travere Therapeutics Inc. TVTX55.1K$3.1 million0.92%new
Humana Inc. HUM7.8K$3.1 million0.92%new
Eli Lilly & Co. LLY2.5K$3.1 million0.90%+2.1K
Revvity, Inc. RVTY27.3K$3.0 million0.89%new
PTC Therapeutics, Inc. PTCT36.9K$3.0 million0.88%-2.8K
AbbVie Inc. ABBV11.9K$3.0 million0.88%new
Chemed Corp. CHE6.4K$3.0 million0.87%new
iShares Trust SOXX4.6K$2.9 million0.87%new
Agilent Technologies, Inc. A21.8K$2.9 million0.85%new
Neurocrine Biosciences Inc. NBIX16.5K$2.8 million0.82%-5.1K
Teva Pharmaceutical Industries Ltd. TEVA82.0K$2.8 million0.82%+56.2K
Astera Labs Inc. ALAB5.3K$2.6 million0.75%new
Cooper Companies, Inc. COO34.7K$2.5 million0.73%+28.8K
Twist Bioscience Corp. TWST20.3K$2.1 million0.61%+6.8K
Qualcomm Inc. QCOM11.1K$2.1 million0.61%new
Acadia Healthcare Company, Inc. ACHC66.8K$2.0 million0.58%new
Davita Inc. DVA8.0K$1.8 million0.53%new
Alnylam Pharmaceuticals Inc ALNY5.6K$1.7 million0.49%new
Concentra Group Holdings Parent, Inc. CON52.7K$1.6 million0.46%new
Biomarin Pharmaceutical Inc. BMRN27.0K$1.5 million0.46%-21.7K
Biogen Inc. BIIB6.8K$1.5 million0.43%+2.1K
Oscar Health Inc. Class A OSCR51.1K$1.5 million0.43%new
Lam Research Corp. LRCX3.2K$1.4 million0.41%new
Select Sector SPDR Trust XLV8.6K$1.4 million0.40%new
Avantor, Inc. AVTR131.1K$1.3 million0.38%new
Rambus Inc. RMBS9.6K$1.3 million0.37%new
iShares Inc. EWT11.1K$1.2 million0.35%-1.4K
Revolution Medicines, Inc. RVMD6.1K$1.1 million0.34%-1.9K
Moderna, Inc. MRNA14.8K$1.0 million0.31%-2.3K
Bridgebio Pharma Inc. BBIO13.5K$1.0 million0.29%+7.7K
Ionis Pharmaceuticals Inc. IONS12.3K$978,2800.29%-26.6K
Select Sector SPDR Trust XLU20.8K$943,0720.28%+4.4K
Invesco Exch Traded FD Trust II QQQM3.1K$939,2070.28%new
Select Sector SPDR Trust XLRE20.0K$880,6000.26%new
Praxis Precision Medicines I PRAX2.5K$823,9180.24%-1.4K
Natera Inc Com NTRA2.8K$763,8600.22%-156
Cytokinetics Inc. CYTK8.8K$752,7390.22%+1.4K
iShares Trust TLT8.7K$751,8540.22%+1.6K
SPDR Ser Trust KRE10.0K$748,5000.22%new
Acadia Pharmaceuticals Inc. ACAD28.7K$726,7430.21%new
Western Digital Corp. WDC1.1K$723,0310.21%new
SPDR Ser Trust XHB6.0K$693,3600.20%new
BioNTech SE BNTX7.3K$679,3580.20%+411
Legend Biotech Corp. LEGN21.7K$625,8010.18%new
SPDR Ser Trust KIE10.0K$609,9000.18%new
Oruka Therapeutics Inc. ORKA6.3K$600,9990.18%+1.2K
Taiwan FLTW5.6K$590,9680.17%+1.9K
United Therapeutics Corp. UTHR1.0K$560,7940.16%+508
Financial Select Sector SPDR ETF XLF9.6K$514,6560.15%+3.4K
Technology Select Sector SPDR ETF XLK2.6K$495,3520.15%+2.4K
Arrowhead Pharmaceuticals, Inc. ARWR5.4K$442,3550.13%new
Marvell Technology, Inc. MRVL1.5K$439,0900.13%new
Alumis Inc. ALMS15.4K$433,2430.13%+3.4K
Illumina, Inc. ILMN2.4K$416,3650.12%-658
Protagonist Therapeutics, Inc. PTGX3.3K$404,2690.12%-6.0K
Anteris Technologies Global AVR39.2K$386,4450.11%new
Cogent Biosciences Inc. COGT9.7K$375,3130.11%-4.1K
Hewlett Packard Enterprise Co. HPE8.2K$369,5860.11%new
Certara, Inc. CERT54.3K$355,8350.10%new
Immunovant Inc. IMVT9.0K$348,4270.10%new
Microchip Technology Inc. MCHP3.8K$344,9180.10%new
Ultragenyx Pharmaceutical in RARE9.8K$328,1900.10%new
Biolife Solutions Inc. BLFS11.6K$327,9230.10%new
Adaptive Biotechnologies Corporation ADPT15.1K$324,9460.10%new
Maravai Lifesciences Hldgs I MRVI50.6K$315,8380.09%new
Cryoport Inc. CYRX20.1K$315,0520.09%new
Belite Bio Inc. BLTE2.0K$309,2020.09%-4.0K
Taiwan Semiconductor Manufacturing Company Limited TSM640$305,6450.09%new
10X Genomics Inc. TXG7.7K$296,1770.09%new
Syndax Pharmaceuticals Inc. SNDX12.8K$278,8240.08%new
Yum China Hldgs Inc. YUMC6.5K$264,5520.08%new
Moonlake Immunotherapeutics MLTX13.5K$262,6310.08%new
Bioage Labs Inc. BIOA10.5K$256,6690.08%-10.3K
Albertsons Companies, Inc. ACI18.7K$252,8620.07%new
Structure Therapeutics Inc. GPCR4.6K$249,2970.07%+455
Tango Therapeutics Inc. TNGX7.7K$239,3890.07%-12.8K
Absci Corporation ABSI19.7K$228,4620.07%new
Enliven Therapeutics Inc. ELVN4.5K$228,3240.07%new
Corvus Pharmaceuticals Inc. CRVS15.1K$225,7730.07%new
Capricor Therapeutics Inc. CAPR9.3K$224,9550.07%new
Maze Therapeatics MAZE7.5K$222,7560.07%new
CME Group Inc. CME1.0K$221,4920.07%new
Bloom Energy Corp. BE729$220,6680.06%new
Mastercard Inc. MA415$213,1440.06%new
Abcellera Biologics Inc. ABCL27.1K$212,6720.06%new
Costar Group, Inc. CSGP7.4K$210,2760.06%new
Otis Worldwide Corp. OTIS2.9K$207,8550.06%new
Mineralys Therapeutics Inc. MLYS7.6K$205,9380.06%new
Eliem Therapeutics Inc. CLYM15.2K$198,7430.06%-9.3K
Silence Therapeutics PLC SLN16.3K$179,3470.05%new
Tal Education Group TAL16.2K$155,3500.05%new
Cleveland-Cliffs Inc. CLF13.2K$123,7230.04%new
Lumen Technologies, Inc. LUMN11.9K$91,7150.03%new
Snap Inc. SNAP20.3K$90,2650.03%new
Newell Brands Inc. NWL14.6K$89,5460.03%new
Plug Power Inc. PLUG28.1K$76,0890.02%+16.9K
Select Sector SPDR Trust XLI400$74,0920.02%-2.9K
JetBlue Airways Corp. JBLU12.7K$72,9140.02%new
Amc Entmt Hldgs Inc. AMC37.2K$70,7330.02%new
Kosmos Energy Ltd KOS28.4K$59,9320.02%new
CCC Intelligent Solutions HL CCC11.0K$56,8580.02%new
Brandywine Rlty Trust BDN16.4K$52,0390.02%+5.7K
Sable Offshore Corp. SOC16.4K$50,6040.01%new
Xerox Holdings Corp. XRX13.2K$41,2030.01%new
Select Sector SPDR Trust XLP300$24,9210.01%-6.0K
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 34 it sold out of are in the box above.

Options it reported

CompanyOptionShares under the optionsValue of those shares
Vaneck ETF Trust SMHCalls80.0K$52.5 million
SPDR S&P 500 SPYCalls40.0K$29.9 million
iShares Inc. EWYPuts86.0K$17.3 million
iShares Inc. EWTPuts112.0K$12.2 million
iShares Trust IGVCalls80.0K$7.2 million

5 option lines. A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost; they are not counted in the holdings above.